Association of functional dopamine-beta-hydroxylase (DBH) 19bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers

Schizophrenia Research

Volumn 141, Issue 1, 2012, Pages 48-53

  Zhang, Xiang Yang ^a,b,c   Chen, Da Chun ^c   Xiu, Mei Hong ^c   Hui, Li ^c   Liu, Haibo ^c   Luo, Xingguang ^d   Zuo, Lingjun ^d   Zhang, Huiping ^d   Kosten, Therese A ^b   Kosten, Thomas R ^b,c,e  

^a INSTITUTE OF PSYCHOLOGY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c PEKING UNIVERSITY   (China)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Association; Dopamine beta hydroxylase; Genotype; Nicotine; Schizophrenia; Smoking

Indexed keywords

CHLORPROMAZINE; DOPAMINE BETA MONOOXYGENASE; NEUROLEPTIC AGENT;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; REWARD; SCHIZOPHRENIA; SCORING SYSTEM; TOBACCO DEPENDENCE;

ADULT; CASE-CONTROL STUDIES; DOPAMINE BETA-HYDROXYLASE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEQUENCE DELETION; SMOKING;

EID: 84865976357     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.07.011     Document Type: Article

References (46)

1. Arrufat F.J., Diaz R., Queralt R., Navarro V., Marcos T., Massana G., Massana J., Ballesta F., Oliva R. Analysis of the polymorphic (GT)(n) repeat at the dopamine beta-hydroxylase gene in Spanish patients affected by schizophrenia. Am. J. Med. Genet. 2000, 96(1):88-92.
2. Brody A.L., Mandelkern M.A., Olmstead R.E., Scheibal D., Hahn E., Shiraga S., Zamora-Paja E., Farahi J., Saxena S., London E.D., McCracken J.T. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch. Gen. Psychiatry 2006, 63:808-816.
3. Chen Y., Wen G., Rao F., Zhang K., Wang L., Rodriguez-Flores J.L., Sanchez A.P., Mahata M., Taupenot L., Sun P., Mahata S.K., Tayo B., Schork N.J., Ziegler M.G., Hamilton B.A., O'Connor D.T. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J. Hypertens. 2010, 28(1):76-86.
4. Cubells J.F., Zabetian C.P. Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 2004, 174(4):463-476.
5. Cubells J.F., Kobayashi K., Nagatsu T., Kidd K.K., Kidd J.R., Calafell F., Kranzler H.R., Ichinose H., Gelernter J. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am. J. Med. Genet. 1997, 74(4):374-379.
6. Cubells J.F., van Kammen D.P., Kelley M.E., Anderson G.M., O'Connor D.T., Price L.H., Malison R., Rao P.A., Kobayashi K., Nagatsu T., Gelernter J. Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum. Genet. 1998, 102(5):533-540.
7. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol. Psychiatry 2000, 5(1):56-63.
8. Cubells J.F., Sun X., Li W., Bonsall R.W., McGrath J.A., Avramopoulos D., Lasseter V.K., Wolyniec P.S., Tang Y.L., Mercer K., Pulver A.E., Elston R.C. Linkage analysis of plasma dopamine beta-hydroxylase activity in families of patients with schizophrenia. Hum. Genet. 2011, 130(5):635-643.
9. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr. Bull. 1996, 22(3):405-409.
10. de Leon J., Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 2005, 76(2-3):135-157.
11. Fagerstrom K.O. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict. Behav. 1978, 3(3-4):235-241.
12. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(2):587-592.
13. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med. 2002, 21(1):35-50.
14. Greenbaum L., Kanyas K., Karni O., Merbl Y., Olender T., Horowitz A., Yakir A., Lancet D., Ben-Asher E., Lerer B. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol. Psychiatry 2006, 11(3):312-322. (223).
15. Hong L.E., Yang X., Wonodi I., Hodgkinson C.A., Goldman D., Stine O.C., Stein E.S., Thaker G.K. A CHRNA5 allele related to nicotine addiction and schizophrenia. Genes Brain Behav. 2011, 10(5):530-535.
16. Hu T.W., Tsai Y.W. Cigarette consumption in rural China: survey results from 3 provinces. Am. J. Public Health 2000, 90(11):1785-1787.
17. Hui L., Zhang X., Huang X.F., Han M., Fernandez F., Yu Y., Sun S., Li W., Chen da C., Xiu M.H., Kosten T.R., Zhang X.Y. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. J. Psychiatr. Res. 2012, 46(6):733-737.
18. Ito H., Hamajima N., Matsuo K., Okuma K., Sato S., Ueda R., Tajima K. Monoamine oxidase polymorphisms and smoking behaviour in Japanese. Pharmacogenetics 2003, 13(2):73-79.
19. Johnstone E.C., Clark T.G., Griffiths S.E., Murphy M.F., Walton R.T. Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. Pharmacogenetics 2002, 12(7):585-587.
20. Jonsson E.G., Abou Jamra R., Schumacher J., Flyckt L., Edman G., Forslund K., Mattila-Evenden M., Rylander G., Asberg M., Bjerkenstedt L., Wiesel F.A., Propping P., Cichon S., Nothen M.M., Sedvall G.C. No association between a putative functional promoter variant in the dopamine beta-hydroxylase gene and schizophrenia. Psychiatr. Genet. 2003, 13(3):175-178.
21. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav. Pharmacol. 2009, 20:1-17.
22. Leonard S., Gault J., Hopkins J., Logel J., Vianzon R., Short M., Drebing C., Berger R., Venn D., Sirota P., Zerbe G., Olincy A., Ross R.G., Adler L.E., Freedman R. Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry 2002, 59(12):1085-1096.
23. Lerer E., Kanyas K., Karni O., Ebstein R.P., Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol. Psychiatry 2006, 11(8):771-781.
24. Li M.D., Cheng R., Ma J.Z., Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98(1):23-31.
25. McKinney E.F., Walton R.T., Yudkin P., Fuller A., Haldar N.A., Mant D., Murphy M., Welsh K.I., Marshall S.E. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000, 10(6):483-491.
26. Nagaya T., Takahashi A., Yoshida I., Yokoyama M. Biphasic effects of smoking on human serum dopamine-beta-hydroxylase activity. Toxicol. Lett. 1992, 60(3):325-328.
27. Novak G., Seeman P., Le Foll B. Exposure to nicotine produces an increase in dopamine D2 (High) receptors: a possible mechanism for dopamine hypersensitivity. Int. J. Neurosci. 2010, 120(11):691-697.
28. Novak G., LeBlanc M., Zai C., Shaikh S., Renou J., DeLuca V., Bulgin N., Kennedy J.L., Le Foll B. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia. Ann. Hum. Genet. 2010, 74(4):291-298.
29. O'Connor D.T., Cervenka J.H., Stone R.A., Levine G.L., Parmer R.J., Franco-Bourland R.E., Madrazo I., Langlais P.J., Robertson D., Biaggioni I. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clin. Sci. (Lond.) 1994, 86(2):149-158.
30. Park J.K., Kim J.W., Lee H.J., Chung J.H., Ha E.Y., Oh D.J., Song J.Y. Dopamine beta-hydroxylase gene polymorphisms and psychotic symptoms in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(7):944-945.
31. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382(6588):255-257.
32. Rossing M.A. Genetic influences on smoking: candidate genes. Environ. Health Perspect. 1998, 106(5):231-238.
33. Shiels M.S., Huang H.Y., Hoffman S.C., Shugart Y.Y., Bolton J.H., Platz E.A., Helzlsouer K.J., Alberg A.J. A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). Prev. Med. 2008, 47(1):116-122.
34. Sullivan P.F., Kendler K.S. The genetic epidemiology of smoking. Nicotine Tob. Res. 1999, 1(Suppl. 2):S51-S57. discussion S69-70.
35. Sullivan P.F., Jiang Y., Neale M.C., Kendler K.S., Straub R.E. Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. Am. J. Med. Genet. 2001, 105(5):479-484.
36. Tobacco and Genetics Consortium Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 2010, 42(5):441-447.
37. Vink J.M., Willemsen G., Boomsma D.I. Heritability of smoking initiation and nicotine dependence. Behav. Genet. 2005, 35(4):397-406.
38. Wei J., Ramchand C.N., Hemmings G.P. A study of the relationship between the DBH activity in serum and a MspI polymorphic site in intron 9 of the human DBH gene in schizophrenia. Schizophr. Res. 1996, 22(1):77-80.
39. Wei J., Ramchand C.N., Hemmings G.P. TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia. Psychiatr. Genet. 1998, 8(1):19-24.
40. Williams H.J., Bray N., Murphy K.C., Cardno A.G., Jones L.A., Owen M.J. No evidence for allelic association between schizophrenia and a functional variant of the human dopamine beta-hydroxylase gene (DBH). Am. J. Med. Genet. 1999, 88(5):557-559.
41. Wilson A.P., Taylor B., Treasure T., Gruneberg R.N., Patton K., Felmingham D., Sturridge M.F. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J. Antimicrob. Chemother. 1988, 21(2):201-212.
42. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64:663-667.
43. Yamamoto K., Cubells J.F., Gelernter J., Benkelfat C., Lalonde P., Bloom D., Lal S., Labelle A., Turecki G., Rouleau G.A., Joober R. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: a genetic association study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 117B(1):33-38.
44. Zabetian C.P., Anderson G.M., Buxbaum S.G., Elston R.C., Ichinose H., Nagatsu T., Kim K.S., Kim C.H., Malison R.T., Gelernter J., Cubells J.F. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 2001, 68(2):515-522.
45. Zhang X.Y., Zhang R.L., Pan M., Chen da C., Xiu M.H., Kosten T.R. Sex difference in the prevalence of smoking in Chinese schizophrenia. J. Psychiatr. Res. 2010, 44(14):986-988.
46. Zhang X.Y., Yu Y.Q., Sun S., Zhang X., Li W., Xiu M.H., Chen da C., Yang F.D., Zhu F., Kosten T.A., Kosten T.R. Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(7):1765-1769.